Autolus Therapeutics Plc (AUTL)
1.72
+0.03
(+1.78%)
USD |
NASDAQ |
Oct 15, 16:00
1.73
+0.01
(+0.58%)
After-Hours: 20:00
Autolus Therapeutics Cash from Operations (TTM) : -224.98M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -224.98M |
| March 31, 2026 | -273.87M |
| December 31, 2025 | -284.23M |
| September 30, 2025 | -254.96M |
| June 30, 2025 | -264.30M |
| March 31, 2025 | -241.32M |
| December 31, 2024 | -206.27M |
| September 30, 2024 | -193.17M |
| June 30, 2024 | -156.38M |
| March 31, 2024 | -143.57M |
| December 31, 2023 | -145.86M |
| September 30, 2023 | -135.52M |
| June 30, 2023 | -127.48M |
| March 31, 2023 | -120.01M |
| Date | Value |
|---|---|
| December 31, 2022 | -112.24M |
| September 30, 2022 | -106.90M |
| June 30, 2022 | -109.74M |
| March 31, 2022 | -115.55M |
| December 31, 2021 | -117.86M |
| September 30, 2021 | -136.43M |
| June 30, 2021 | -140.75M |
| March 31, 2021 | -131.07M |
| December 31, 2020 | -117.76M |
| September 30, 2020 | -123.30M |
| June 30, 2020 | -108.72M |
| March 31, 2020 | -99.00M |
| December 31, 2019 | -101.48M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Bicycle Therapeutics Plc | -205.24M |
| Biodexa Pharmaceuticals Plc | -9.219M |
| argenx SE | 1.160B |
| Mereo BioPharma Group Plc | -25.28M |
| Evaxion AS | -- |